Tocilizumab 162Mg/0.9Ml Autoinjector

( DrugBank: Tocilizumab / KEGG DRUG: Tocilizumab )

1 disease

ID	Disease name (Link within this page)	Number of trials
41	Giant cell arteritis	1

41. Giant cell arteritis

Clinical trials : 131 / Drugs : 139 - (DrugBank : 36) / Drug target genes : 33 - Drug target pathways : 125

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05394909 (ClinicalTrials.gov)	February 7, 2020	20/5/2022	Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients	Treatment Of Giant Cell Arteritis Patients With Ultra-short Glucocorticosteroids And tociliZumab: Ro ...	GCA;TOCILIZUMAB;Glucocorticoids;PET	Drug: Tocilizumab 162Mg/0.9Ml Autoinjector	Azienda Unità Sanitaria Locale Reggio Emilia	NULL	Active, not recruiting	N/A	N/A	All	20		Italy